Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration

Gadolinium-based contrast agents (GBCAs) have transformed magnetic resonance imaging (MRI) by facilitating the use of contrast-enhanced MRI to allow vital clinical diagnosis in a plethora of disease that would otherwise remain undetected. Although over 500 million doses have been administered worldw...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, Julie, Siebenhandl-Wolff, Petra, Tranquart, Francois, Jones, Paul, Evans, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837552/
https://www.ncbi.nlm.nih.gov/pubmed/34997254
http://dx.doi.org/10.1007/s00204-021-03189-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837552/
https://www.ncbi.nlm.nih.gov/pubmed/34997254
http://dx.doi.org/10.1007/s00204-021-03189-8

Ejemplares similares